199 related articles for article (PubMed ID: 29770709)
21. Bridging Translation by Improving Preclinical Study Design in AKI.
de Caestecker M; Humphreys BD; Liu KD; Fissell WH; Cerda J; Nolin TD; Askenazi D; Mour G; Harrell FE; Pullen N; Okusa MD; Faubel S;
J Am Soc Nephrol; 2015 Dec; 26(12):2905-16. PubMed ID: 26538634
[TBL] [Abstract][Full Text] [Related]
22. Contrast-induced nephropathy in patients undergoing elective and urgent procedures.
Mautone A; Brown JR
J Interv Cardiol; 2010 Feb; 23(1):78-85. PubMed ID: 20465721
[TBL] [Abstract][Full Text] [Related]
23. AKIGUARD (Acute Kidney Injury GUARding Device) trial: in-hospital and one-year outcomes.
Usmiani T; Andreis A; Budano C; Sbarra P; Andriani M; Garrone P; Fanelli AL; Calcagnile C; Bergamasco L; Biancone L; Marra S
J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):530-7. PubMed ID: 26702595
[TBL] [Abstract][Full Text] [Related]
24. [Value of N-acetylcysteine to prevent nephrotoxicity from iodinated contrast agents].
Deray G
J Radiol; 2004 Jun; 85(6 Pt 1):725-7. PubMed ID: 15243372
[TBL] [Abstract][Full Text] [Related]
25. Protection from contrast-induced nephropathy: is the answer in?
Dean LS
Catheter Cardiovasc Interv; 2003 Mar; 58(3):342-3. PubMed ID: 12594699
[No Abstract] [Full Text] [Related]
26. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study.
Albabtain MA; Almasood A; Alshurafah H; Alamri H; Tamim H
J Interv Cardiol; 2013 Feb; 26(1):90-6. PubMed ID: 22994682
[TBL] [Abstract][Full Text] [Related]
27. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
Vasheghani-Farahani A; Sadigh G; Kassaian SE; Khatami SM; Fotouhi A; Razavi SA; Mansournia MA; Yamini-Sharif A; Amirzadegan A; Salarifar M; Sadeghian S; Davoodi G; Borumand MA; Esfehani FA; Darabian S
Am J Kidney Dis; 2009 Oct; 54(4):610-8. PubMed ID: 19619921
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Subramaniam RM; Suarez-Cuervo C; Wilson RF; Turban S; Zhang A; Sherrod C; Aboagye J; Eng J; Choi MJ; Hutfless S; Bass EB
Ann Intern Med; 2016 Mar; 164(6):406-16. PubMed ID: 26830221
[TBL] [Abstract][Full Text] [Related]
29. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.
Kay J; Chow WH; Chan TM; Lo SK; Kwok OH; Yip A; Fan K; Lee CH; Lam WF
JAMA; 2003 Feb; 289(5):553-8. PubMed ID: 12578487
[TBL] [Abstract][Full Text] [Related]
30. [Iodinated contrast agent-induced nephropathy].
Erley C
Radiologe; 2007 Sep; 47(9):761-7. PubMed ID: 17823784
[TBL] [Abstract][Full Text] [Related]
31. Are we still wondering or wandering in the dark?
Cattano D
Intern Emerg Med; 2011 Dec; 6(6):485-6. PubMed ID: 21416287
[No Abstract] [Full Text] [Related]
32. Contrast-induced nephropathy: a review.
Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N
Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365
[TBL] [Abstract][Full Text] [Related]
33. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
34. PrevenTion of contrast-inducEd nephropAThy with urinE alkalinization: the TEATE study design.
Lombardi M; Molisana M; Genovesi E; De Innocentiis C; Limbruno U; Misuraca L; Moretti L; Di Vito L; Di Nicola M; Zimarino M; Renda G; De Caterina R
J Cardiovasc Med (Hagerstown); 2020 Jan; 21(1):65-72. PubMed ID: 31688431
[TBL] [Abstract][Full Text] [Related]
35. Hydration: Intravenous and Oral: Approaches, Principals, and Differing Regimens: Is It What Goes in or What Comes Out That Is Important?
Solomon R
Interv Cardiol Clin; 2020 Jul; 9(3):385-393. PubMed ID: 32471678
[TBL] [Abstract][Full Text] [Related]
36. Of hypes and hopes: N-acetylcysteine and cystatin C.
Schultz MJ; Royakkers AA; Bouman CS
AJR Am J Roentgenol; 2008 Mar; 190(3):W224; author reply W225. PubMed ID: 18287418
[No Abstract] [Full Text] [Related]
37. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
Goldenberg I; Shechter M; Matetzky S; Jonas M; Adam M; Pres H; Elian D; Agranat O; Schwammenthal E; Guetta V
Eur Heart J; 2004 Feb; 25(3):212-8. PubMed ID: 14972421
[TBL] [Abstract][Full Text] [Related]
38. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
[TBL] [Abstract][Full Text] [Related]
39. Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study.
Moore NN; Lapsley M; Norden AG; Firth JD; Gaunt ME; Varty K; Boyle JR
J Endovasc Ther; 2006 Oct; 13(5):660-6. PubMed ID: 17042662
[TBL] [Abstract][Full Text] [Related]
40. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
